N
Google TrendMAX CASTER (200+) — Moose Def. Max Caster At TNA Bound For Glory 2026
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Google Trends:max caster200+prince harry family photo story200+kelley knockel500+torino vs udinese200+coventry vs newcastle5000+levante - sevilla2000+servicio de control de inmigración y aduanas1000+indigo girls500+
Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "Phase 3 Data Highlight Ha" (30 stories)

Top Headline Story

RedHill Biopharma Announces Operational Highlights and First Half 2026 Financial Results
Lead StoryPR Newswireworld
Sep 30

RedHill Biopharma Announces Operational Highlights and First Half 2026 Financial Results

<a href="https://news.google.com/rss/articles/CBMi4AFBVV95cUxPNlU0NUE3WTY1TC1CanlPVWtjWlBTUi1YYWFqeThaZnNKX1NxazRjTjlsMHpDMGxFX2lDYmlfT2F4SFNPZS1mbDFwVFZraUtrT1lKQmpEWDBkRXNaQ3dGWThKUC1oaU9CR1F1bDdRellvU1RuZ0JXYUlSYTcyY2hQdmhxNGVMcGdNRGFCVDhYbTlsYU0tNnZ1WkdyWC1vNHViNU4wbkQta0w2UWJhM0NReGE4WWREcW43dXAzV29FMTh3Q0NVdTJPeDhXbnJiblBNcnpTaG1xZndUdjJFTTJwWQ?oc=5" target="_blank">RedHill Biopharma Announces Operational Highlights and First Half 2026 Financial Results</a>  <font color="#6f6f6f">PR Newswire</font>

Read Full StoryRelated Trends

Google Trends & Trending Search Intelligence

Real-time search volume
200+20m ago

max caster

Moose Def. Max Caster At TNA Bound For Glory 2026

Filter stories
200+20m ago

prince harry family photo story

Prince Harry Reveals the Photo He Took of Archie and Lilibet That ‘Fills My Heart’

Filter stories
500+30m ago

kelley knockel

1 dead, multiple injured after pair of motorcycle crashes involving deer in Iowa

Filter stories
200+30m ago

torino vs udinese

Torino vs Udinese: Italian Serie A stats & head-to-head

Filter stories

Search Results for "Phase 3 Data Highlight Ha"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
Will Positive Phase 3 Anxiety Data Change Definium Therapeutics' (DFTX) Narrative
Simply Wall Streetgeneral

Will Positive Phase 3 Anxiety Data Change Definium Therapeutics' (DFTX) Narrative

<a href="https://news.google.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?oc=5" target="_blank">Will Positive Phase 3 Anxiety Data Change Definium Therapeutics' (DFTX) Narrative</a>  <font color="#6f6f6f">Simply Wall Street</font>

Read Full StoryMore like this
New Phase 3 Clinical Vocal Biomarker Data on Brilaroxazine to Treat Negative Symptoms in Schizophrenia
Psychiatric Timesgeneral

New Phase 3 Clinical Vocal Biomarker Data on Brilaroxazine to Treat Negative Symptoms in Schizophrenia

<a href="https://news.google.com/rss/articles/CBMi1wFBVV95cUxPSmhtMFJLYXJCcGx6RW1RZHNVZTZQV25ORVFLZ1ZYTnZtNmJQX1pnSUZkcTVyQXRZME5yMWxKbUJ2WHJnSk5FYVJOSDRvdks0bUJ1b3c3N2pncGhiblJBSUE5RG1vUkc1Z092bjlMM1EyUFJWdXBGUjNYaXU4eF9ITm9qdmNRdF9yRUVjeklPRlhYVEx1Vk5EYXFQYlNTZ0tEYllGX3Nwd3cxd2Zocm1ZdkVtdlBKMjBiaUIxakw5c1JKdUY0YWdQeGlNYTJBREpBQm9LcXJOcw?oc=5" target="_blank">New Phase 3 Clinical Vocal Biomarker Data on Brilaroxazine to Treat Negative Symptoms in Schizophrenia</a>  <font color="#6f6f6f">Psychiatric Times</font>

Read Full StoryMore like this
Archer Announces First Quarter 2026 Results, Highlighting Record FAA Certification Progress With Initial US Operations Expected In 2026
Archer Aviationworld

Archer Announces First Quarter 2026 Results, Highlighting Record FAA Certification Progress With Initial US Operations Expected In 2026

<a href="https://news.google.com/rss/articles/CBMipgJBVV95cUxOc1UyTnhsZ09NS2s1M2NncEZiZEkyYkZzVVNGZmZYM3puanVfeXd6bkZxSl8zZWFYWmtlX21YUjNCcVFPdFVJbFk3dTFtRjZFRGhWMEx4V0dnUmxHeVhya2RKbWZ0eEFVaGE0aDB4cE1sWnZmcVVrVTBaZ0o4YzlVT0dsU29iZUhvbHQ4cnJna2JkblludzlYbkJuaXJFdEN5TmRISm4tSW1jUXhvUXJqa1lNaXZjTkM3YS16VUtLcGtzdWNzcnFuMjFTRGpuSDlzY3liWmtVSHVfdW5OM1VSallvNVhjZUpSOVFka3BKT3N0bV9BLWU2ajZkMURucGRGZTJ6NDhDTzVJS29PS2lqNzJLLXUtal81VjJHUGZtNUVXS2Z2RUE?oc=5" target="_blank">Archer Announces First Quarter 2026 Results, Highlighting Record FAA Certification Progress With Initial US Operations Expected In 2026</a>  <font color="#6f6f6f">Archer Aviation</font>

Read Full StoryMore like this
FDA Approves First Orexin Agonist for Narcolepsy Type 1
The American Journal of Managed Caregeneral

FDA Approves First Orexin Agonist for Narcolepsy Type 1

<a href="https://news.google.com/rss/articles/CBMigwFBVV95cUxOWVdjZ3d6Y2lhY29OMHdDREpWOXJ1V3MzZ1NnUW9kc0NpSkxuaDV5UkdHbWdkbDFzMWM0MGFBRU1YeFo0RU5sdTFuRllZaUw2MkVUbC0wUElUcE16WDIxdTlfam5zUHdMRG5rSS12NUhoVG1Ndm0wR29OZllLVFdJY1h4Yw?oc=5" target="_blank">FDA Approves First Orexin Agonist for Narcolepsy Type 1</a>  <font color="#6f6f6f">The American Journal of Managed Care</font>

Read Full StoryMore like this
Galderma Unveils New Interim Trial Data on Menopause and Weight Loss-Driven Skin Changes
Dermatology Timesworld

Galderma Unveils New Interim Trial Data on Menopause and Weight Loss-Driven Skin Changes

<a href="https://news.google.com/rss/articles/CBMixAFBVV95cUxNTGJON0J4cHJ4ZTdmSkZkOWNPOFZLY1FNSWNZRjVROG9jOF9fdUh1QXpNLXBhSEUteHF5OUpSWmZZS3ZsSVZmUUVpdDVXTEl2emZJNmxQVGFQV3BMV0g4SVc4RG5jYnMtRVVrMWRad2QwSXl1Zk1TU01JRnZ2aGd0aHdwcEU1YmJQaUd3bXI1MktGM04wQl9rd2lyTkEta09VRzcyVVlHTmZoWWo2eXBUOWtYaE5vM1RsUHd5VDBmTWFWZ3dn?oc=5" target="_blank">Galderma Unveils New Interim Trial Data on Menopause and Weight Loss-Driven Skin Changes</a>  <font color="#6f6f6f">Dermatology Times</font>

Read Full StoryMore like this
ARVO 2026 signals a turning point for retina innovations
Glance by Eyes On Eyecaregeneral

ARVO 2026 signals a turning point for retina innovations

<a href="https://news.google.com/rss/articles/CBMirgFBVV95cUxObnI5MGE2akM4aGtqRzNxTlZqX2hKSnVEOHA0RXV6V0p1ak1xSmdSV2diYVBveGk0Wmlxb3FPb3JzYnRKeWNxQ0pHa3QxcXdPbHZGazBkWjhDMklCRTB1N2RocWY4aEZrZVI1cGhVWTljSTlNeXJ5T0YwT3JKM1dGdlYyelpFZFdjUlhVWjJ4aHBRUEJ1MFlPbVFnREhkSTJuTnhHVHdLTEFGSGVPUFE?oc=5" target="_blank">ARVO 2026 signals a turning point for retina innovations</a>  <font color="#6f6f6f">Glance by Eyes On Eyecare</font>

Read Full StoryMore like this
Cognito Therapeutics to Present New Data Highlighting Effects of Spectris™ on Lipid Transport Biomarkers in Alzheimer’s Disease at AAIC 2026
BioSpacetech

Cognito Therapeutics to Present New Data Highlighting Effects of Spectris™ on Lipid Transport Biomarkers in Alzheimer’s Disease at AAIC 2026

<a href="https://news.google.com/rss/articles/CBMiigJBVV95cUxORHhsZkh2Z3JmUDdmRUltaDdmcV9ySERFaG1HTldEc2RicTNCQ1V3WXBLVnhPd0lTaWo2UUM0bGJRY2FDakN6cXVQalV6QktmZTJOUnFFbVFueGlmM2dLeTJlZ2VvbmdiWTdQeWxoNlpzSzhNcVRkdkRGRlpUX21YQkRPVmZrQ3pCVm9sYVJSdkxSRnUzNWV5US03cVFrcjAzSUZIa1BiVmxiOWh5NWtuSHRtSkNTMTJ2TmNtejl0TUFlM3lBREFUV2JNdXhJNDRnMjktdTlnZV9YNnVFQmZ0TmpRY1RLZFBGSE93QUFrMzdFdmppZWY5RnA2RmVIYlNER1d4OG9SMWVMdw?oc=5" target="_blank">Cognito Therapeutics to Present New Data Highlighting Effects of Spectris™ on Lipid Transport Biomarkers in Alzheimer’s Disease at AAIC 2026</a>  <font color="#6f6f6f">BioSpace</font>

Read Full StoryMore like this
Epicrispr Reports First Clinical Evidence of Increased Lean Muscle Volume in Patients with FSHD Following Treatment with EPI-321
Business Wiregeneral

Epicrispr Reports First Clinical Evidence of Increased Lean Muscle Volume in Patients with FSHD Following Treatment with EPI-321

<a href="https://news.google.com/rss/articles/CBMikwJBVV95cUxPeVp3bW1mNUtWVUpzLUlNWm5TMjROQzZFWlRKdXBuWEowdks3YWF3SjlmeEhuSmZocTFMZ2RnTy1YNjlxUFo4ajBuYjlHandsUWpMNTRBb3V3RUNUTUxMak9JdUR3cXl6Mzd3dTJYOThnUy0zWm1VZ1NyMUNlank2dmhDTHJiNWowXy1MVUQyRTIwN3U4bWhua2pMMVZqWEhULWNEWkpaQ3BnLXRHVzkxM3d2d2hiZDd2a1QzakFNNTJud0loWjVrU3gxQ24wWXBDRm5pQVA0NGE4RTB3bm45Smcyc0VEV2JLa2l6WDFKR0xoQmY1UXlvVTBnV2luMVpFaVFkeWh5dGs1THVESEtOZUZ5TQ?oc=5" target="_blank">Epicrispr Reports First Clinical Evidence of Increased Lean Muscle Volume in Patients with FSHD Following Treatment with EPI-321</a>  <font color="#6f6f6f">Business Wire</font>

Read Full StoryMore like this
Allergan Aesthetics Unveils New Data at 2025 American Society for Dermatologic Surgery Annual Meeting Showcasing Transformative Innovation and Portfolio Excellence
AbbVie News Centerworld

Allergan Aesthetics Unveils New Data at 2025 American Society for Dermatologic Surgery Annual Meeting Showcasing Transformative Innovation and Portfolio Excellence

<a href="https://news.google.com/rss/articles/CBMipAJBVV95cUxNbGtBRzFoWHFXTE1oZlA2LXVwaG5mdy1wSDVIZ0t3LXhZY0h2V0g1bVk4OU44cnZXVEdpQzBxeFNUTkFfNVdiQUZQZEp4dE9wcWVTZU9wYXlsVVgtZVJiOEtpaE5ScDhKcjJmWXBVQ1EzODZTaG5MQ25mZmlyWlM0Y0xfMFVJM2pJSm5PXzJQclRlX21iWXRQMlhJTFhsSnN0UlB4RW5memhLclp0WllROVBWNE95a2JZRkkwRFNncmtPNVFFc2hwbzFnRmg2eG81bk1SdmdTQnQtMTJJUU44SXJrTjNCZHViMVVGb3VXYmFHRktyQm5pYUV3VHN2WWFEenE0SEdsS2JpQkZpSmxiY3liNXlpNXpkTlJTSmRBV2k1Wm9v?oc=5" target="_blank">Allergan Aesthetics Unveils New Data at 2025 American Society for Dermatologic Surgery Annual Meeting Showcasing Transformative Innovation and Portfolio Excellence</a>  <font color="#6f6f6f">AbbVie News Center</font>

Read Full StoryMore like this
Influenza vaccines promote humoral and cellular immune responses: a randomized, double-blind, phase 3 trial
Natureworld

Influenza vaccines promote humoral and cellular immune responses: a randomized, double-blind, phase 3 trial

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5yYm1QNGt5SmhtdVlkUEhzSDJ3dm1PMjlPY3NqaE1EejVvS3FGN09rbGtDc1dHVlhPMjExeldkcVJmT0hLUlZhbDBydVJJR3hkbVlWZFhacjVuYjFRWFFF?oc=5" target="_blank">Influenza vaccines promote humoral and cellular immune responses: a randomized, double-blind, phase 3 trial</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Gossamer Bio Q1 Earnings Call Highlights
TradingViewgeneral

Gossamer Bio Q1 Earnings Call Highlights

<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxNODVtcHFTd0FlYzRYeGJxdG9yc0tXT3JDNkMwY18yTVAtLXJWS3pvUk5Pa3YxdVFGT3N2SlZ1VS1KdE9aak54Q0xqSm44SmZCekVZY3Z3d2xHT1FrbG9xUXdFaEdWZVdIdWZ3SF91elJLTEFfN0t5REs0SkprU2JjckwwbkRpSEZWd1JVR2RPWTE5YmpoZjBhcXNGeFRkY0hxZ3c?oc=5" target="_blank">Gossamer Bio Q1 Earnings Call Highlights</a>  <font color="#6f6f6f">TradingView</font>

Read Full StoryMore like this
Intellia Therapeutics Announces Positive Three-Year Data from Phase 1 Trial of Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema (HAE) at the European Academy of Allergy and Clinical Immunology Congress
Intellia Therapeuticsworld

Intellia Therapeutics Announces Positive Three-Year Data from Phase 1 Trial of Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema (HAE) at the European Academy of Allergy and Clinical Immunology Congress

<a href="https://news.google.com/rss/articles/CBMiwwFBVV95cUxPNDl4aVF3RGF5RVprcDcwWExtYlFqaEkwd29qUmsxbkJyQ28tSEpfSFdwYjBsQXVWNUZXaVpzR0tUWFhhT09sUFpyem5qeVVqaGp1ZzJDOVpldzhuRkxoODZ6MHhaNDFDc3J5MmNxN1dFYUNyY2EtQzRuMWt5VVZNMjhVMmN2N1dYZUIxdFoxbkpGc2hCU1lMTGQwSWhrWDgxR2JQNHdEU0k3ZUNicVljMjhncDg2ZUFJTHRCbnJRa2hmWDg?oc=5" target="_blank">Intellia Therapeutics Announces Positive Three-Year Data from Phase 1 Trial of Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema (HAE) at the European Academy of Allergy and Clinical Immunology Congress</a>  <font color="#6f6f6f">Intellia Therapeutics</font>

Read Full StoryMore like this
ASDS 2025: Compelling New Data on Restylane, Sculptra and Relfydess Highlight Galderma’s Innovative Injectable Aesthetics Portfolio and Pipeline
BioSpacegeneral

ASDS 2025: Compelling New Data on Restylane, Sculptra and Relfydess Highlight Galderma’s Innovative Injectable Aesthetics Portfolio and Pipeline

<a href="https://news.google.com/rss/articles/CBMijgJBVV95cUxOZnZYdlZvQ2VRVDZjeFFSZkFfTmU3UVJVUDVRWEw4bVNMb002bG4zWWNRbHd5ekpTTGd4T0E1MGJMSFB1bmtOXzN6TVdzeUc1YlFSQ2d4Sk5mX3VHT0NrM2ZlcWxKWFhtU254bWVRZm5PLWV0a1NsM181d0RGOHBveUtVNFdIMEFSQjBRRW05SEN0dEtwVnhYVzRrTW12NkIzb3pRbWRWbVNYeHM1YVNtdXBtSVpxZ2h6aC03N3l6d0Y1YklYTW5PMlhDNDBfSXNIdkpiaUVYUEFESW5EQ0NnM2hNcGVFTHFVNWd0dWpTSzVaUjZsaDIzMnZNbEl1Y1JRYlYtSTNLY3NXcmd6aGc?oc=5" target="_blank">ASDS 2025: Compelling New Data on Restylane, Sculptra and Relfydess Highlight Galderma’s Innovative Injectable Aesthetics Portfolio and Pipeline</a>  <font color="#6f6f6f">BioSpace</font>

Read Full StoryMore like this
Taguchi optimisation of ZnO and GO-integrated HA nanocomposite with improved antibacterial performance
Naturegeneral

Taguchi optimisation of ZnO and GO-integrated HA nanocomposite with improved antibacterial performance

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE40LVhyNEdDajk4WERzWTV6SmR1RUNOYjRzWkZaRVhVVVJlSUpfWXlyUDdWNHB4QVpNWk1yWnJMMmxfZVpZUFBnUmxXNnFHeHg4ZnV4UThtVG8yTE1OMmJV?oc=5" target="_blank">Taguchi optimisation of ZnO and GO-integrated HA nanocomposite with improved antibacterial performance</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
AMWC 2026: Galderma Showcases Category‑leading Innovation With a Comprehensive Portfolio and Holistic, Future‑focused Aesthetic Strategies
Business Wiregeneral

AMWC 2026: Galderma Showcases Category‑leading Innovation With a Comprehensive Portfolio and Holistic, Future‑focused Aesthetic Strategies

<a href="https://news.google.com/rss/articles/CBMimwJBVV95cUxQMjdmR0QtZWtFQkZOLWNnOFRybU5sQ2JXM3JibkxEYmE3THNSbkNtQ0tlczg4YS1hQWxENEtaTzRIR21oMWp0YzFjeGptd29ZdC1OVVB4d1c1Wnd0MU1mUUc4djYxMElQcXNtZ29OUkhGY1E1cGRsTF9GWWhtLUF0cVNVV09wckE2dmZHQnNtQlh5b0Q1TkEtNW45NGhXN3lPQ3pQbVZjU1VnS3BzZlA3cU9mWENEeVRGYWhCUms2ZUFNRHNybGwxXzBfWUw3RHVFUThKWk93WjVPMHRyWloyMlByWWU3bERVX01JNFNQZ20wWGVGT09CbXE1MU85ZjlXZ2lrMk01bkVhaUhmSlc4c1R5cEZQWG5xWldV?oc=5" target="_blank">AMWC 2026: Galderma Showcases Category‑leading Innovation With a Comprehensive Portfolio and Holistic, Future‑focused Aesthetic Strategies</a>  <font color="#6f6f6f">Business Wire</font>

Read Full StoryMore like this
WCLC 2025: The Top 5 Takeaways Across Lung Cancer Care
CancerNetworkworld

WCLC 2025: The Top 5 Takeaways Across Lung Cancer Care

<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxOYnU2cEI2SVUwZjdQWlJHamtkOS14blFNSG8ybHdERmtqWWtrSmpVd3dDQUZpM0pKNWh1Um5aRlpHbHdld1ZHeVJDUEFMQ3RUSW0tZ1Zmd1JVM09jMElYekVXYzJOU01qZGhZekhDOXN3NFl4alBWV0w3T01lUE1jemJjYjJEeVBHeEFDRW1OZHJUZw?oc=5" target="_blank">WCLC 2025: The Top 5 Takeaways Across Lung Cancer Care</a>  <font color="#6f6f6f">CancerNetwork</font>

Read Full StoryMore like this
Phase 3 Data for Sotatercept in PAH Meets Mark for Walk Test; Huge Drop Seen in Risk of Death and Clinical Events
AJMCgeneral

Phase 3 Data for Sotatercept in PAH Meets Mark for Walk Test; Huge Drop Seen in Risk of Death and Clinical Events

<a href="https://news.google.com/rss/articles/CBMi1AFBVV95cUxNdWxINXJZZkpPMmE3Q25oQmRHM3hTdWQ0RXRrQU16cm1wTFI4ZVlmZjBacHdVdWxWcEpfenprNWFpdWVWSktqV19xM21fNVFsOERFVDlndW1tbXQzeVgzQmROUGMwd09HU1Y2anJLWm9FZlBKX2xCTGRMdzhlZndmc3hsUko4ZmotR0l1X0ZmbGpqbDJiSVNLZkJOZl9yZmRPclZEdHRZQnVFQ3dDSXBtanZUTkNLM0ZneGFXU1djVFA0WnVCZ0JYd1c1QjVvRDlCQTFSTA?oc=5" target="_blank">Phase 3 Data for Sotatercept in PAH Meets Mark for Walk Test; Huge Drop Seen in Risk of Death and Clinical Events</a>  <font color="#6f6f6f">AJMC</font>

Read Full StoryMore like this
Circulating tumour DNA assays in focus: highlights from ASCO 2025 for clinicians | BJC Reports
Naturegeneral

Circulating tumour DNA assays in focus: highlights from ASCO 2025 for clinicians | BJC Reports

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBwMnowN2ZqMFotSGlIR1UxT2pBU2N2c3FuVmRUb2tWakNYNW1tRUZpckpIdjBmRDQ0SHRnUWdUTUg1NkxreEp4RnJUMDFGWkZ6RHJhQ0RsYVlMbnZVVVRJ?oc=5" target="_blank">Circulating tumour DNA assays in focus: highlights from ASCO 2025 for clinicians | BJC Reports</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Lilly's Donanemab Significantly Slowed Cognitive and Functional Decline in Phase 3 Study of Early Alzheimer's Disease
Eli Lillyworld

Lilly's Donanemab Significantly Slowed Cognitive and Functional Decline in Phase 3 Study of Early Alzheimer's Disease

<a href="https://news.google.com/rss/articles/CBMiwgFBVV95cUxPclBzb1VMSmxQakFYUWdZTV8tTGNoRHFUQlE0M3podV9QOTdfZjE3WkVsVHVqWTljYkl4ajBXNFMtRW9OOEF6RDhEaTFDMVVyeGY5TWpKUjBBZGROck04Y3dicFJEd21ELU9HT2t3a21hLVNZaVhTN1VtVXRFaWZYaXFBRmZlekhlRlpwMVFiQkFlbFYyaHZQbFpjTGpXbC0tN3UxUWFlalJxTEJ1VVd0bWphcXNNM0ZDWWZMOHk0UUVmZw?oc=5" target="_blank">Lilly's Donanemab Significantly Slowed Cognitive and Functional Decline in Phase 3 Study of Early Alzheimer's Disease</a>  <font color="#6f6f6f">Eli Lilly</font>

Read Full StoryMore like this
Global Climate Highlights 2023
Copernicus Climate Changescience

Global Climate Highlights 2023

<a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE84TG5WeXBxeXhER2xTT3dQaFdmLS1HelhFQWpZRW95TVp2c0Itall0bzdCUG1mZ25feWJNT1ZMTm01ckw5LWIyNkp5Rmw1WjBrYWMzcUE3TDZfV0M2bkZOVkprYzNKZ2MwYTliZA?oc=5" target="_blank">Global Climate Highlights 2023</a>  <font color="#6f6f6f">Copernicus Climate Change</font>

Read Full StoryMore like this
Phase 3 trial of lanifibranor for MASH completes enrollment
Liver Disease Newsgeneral

Phase 3 trial of lanifibranor for MASH completes enrollment

<a href="https://news.google.com/rss/articles/CBMikAFBVV95cUxORzNjNUloU2NrRDZlVzh0c3lLN1hfRGtwNllyamhaZ0RvbHBWcTNyODR4dTdmS2pyMDdoeGNsVWJyOEJkUEJIUElGbUhFUlhoTjRhQmdLOXNOT0hmNjFpaXREcmFMTGZ2QjBEdnJ0SVB5V3RJeUUtS1lGVkR3WGtMaUJIMHpGSl9id2tHR3B4Smc?oc=5" target="_blank">Phase 3 trial of lanifibranor for MASH completes enrollment</a>  <font color="#6f6f6f">Liver Disease News</font>

Read Full StoryMore like this
BI 764532 Earns FDA FTD in SCLC and Extrapulmonary Neuroendocrine Carcinoma
CancerNetworkgeneral

BI 764532 Earns FDA FTD in SCLC and Extrapulmonary Neuroendocrine Carcinoma

<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxPQXMxRnpMMWxGVlVteWtXYzFhODcwSjFheDluOEc0dGhrVmJOaWFrVGlaQlZWdHB1c0p3Qmp1Z0t1WW8xYk5VaGZMdW1KRFlyR3pVUTRZSTdiM0ZUTmZRaHQ1S2xLTGU0SF9JY0I2QmRFU0k5aXlhTTFqQldkbWdFeHI5UWRqa1dEZWRHeFVxclFwSHo3bHNWMHNab2hDNU5xLWtCRjRacHJTaF9YWUxR?oc=5" target="_blank">BI 764532 Earns FDA FTD in SCLC and Extrapulmonary Neuroendocrine Carcinoma</a>  <font color="#6f6f6f">CancerNetwork</font>

Read Full StoryMore like this
Copernicus: 2024 is the first year to exceed 1.5°C above pre-industrial level
Copernicus Climate Changegeneral

Copernicus: 2024 is the first year to exceed 1.5°C above pre-industrial level

<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxOUzRkRjBDQURMM2VaVi0yUzdSMnV6VS12eW9HUEpMZ2dQYlluTERmY3cwdERsOTgwNFQwWFQ4VWExVGVBMU4xbk9HU1hPWnVIWHFxYlhNdkhjQnRFc2I5LWpKa3FMd3ZwTExNRUNZaGpxVlo3d2R5LXFoN0hsYXE5eXBJVjI0UXFuZFdVRHhaZWJjN0VfN3J4eTBSWEFqZw?oc=5" target="_blank">Copernicus: 2024 is the first year to exceed 1.5°C above pre-industrial level</a>  <font color="#6f6f6f">Copernicus Climate Change</font>

Read Full StoryMore like this
Drug–Fc conjugate CD388 targets influenza virus neuraminidase and is broadly protective in mice
Naturegeneral

Drug–Fc conjugate CD388 targets influenza virus neuraminidase and is broadly protective in mice

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5SVTNhOFdxcDR4LWZ5U0pfMW5sRkxkV2Jra19vRXhuR19FMXc2blhJY1gyZ3lDbnltc0RaRFdUWXp0eG83dEJkd3VsX2U1WXNjanJhcWktTEsxcUt4OWln?oc=5" target="_blank">Drug–Fc conjugate CD388 targets influenza virus neuraminidase and is broadly protective in mice</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Allergan's New Campaign and Data Report Fights Misinformation on Hyaluronic Acid Fillers
Dermatology Timestech

Allergan's New Campaign and Data Report Fights Misinformation on Hyaluronic Acid Fillers

<a href="https://news.google.com/rss/articles/CBMixAFBVV95cUxNQ1N3OF82UDFPZVJxYnJTa1FFWFBGdDg3czdiLWp1VGxXb3RYcTBEV0UyaXpGYUFLZE16YkJaUmN2Q2JuUUFsYkhNQXRvZV9LM21hS2pORGxmbWNRV1dyY1ZuQTBFWlZNWklWV1RQaFJ2bmJnYjh3eEVaMm1CbUFKaHQ3UTcwYUQ0UlJpWHlPWGdFb094YzJmNktOcE9PTGNILTVGYkV5QjRPR0JfNkFSVFoxeE0tRktBZzh5U05zY05ST0hM?oc=5" target="_blank">Allergan's New Campaign and Data Report Fights Misinformation on Hyaluronic Acid Fillers</a>  <font color="#6f6f6f">Dermatology Times</font>

Read Full StoryMore like this
Negri Sembilan's growth story unfolds beneath political storm [WATCH]
KLSE Screenerworld

Negri Sembilan's growth story unfolds beneath political storm [WATCH]

<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxPWFByak5iVGY4ek41ZXdkekhRb04yZG5oR2RoY2ZnSDkxSUJnZFkzWEkyNkg1OFdDcERqZk1uV3pnRnVRa3JRLThnZDhMajNvaUgzcFhXdWhtNUZZVjJjTkczUjNmWFJ4TEZiN0p2NDFjTGIwZnBHYjVadkVpSVk3NWM0WjN1Z3BPOXNRZklJSGtkQk1rQnBfZFZQOHFzYXZNRmdBU0ZnMmtwRF9WSm1lR1VBNGpnRGpERFZQb3p3?oc=5" target="_blank">Negri Sembilan's growth story unfolds beneath political storm [WATCH]</a>  <font color="#6f6f6f">KLSE Screener</font>

Read Full StoryMore like this
MONALEESA-2 Subgroup Analysis Highlights Survival Benefit With Ribociclib/Letrozole in HR+ Breast Cancer
OncLivegeneral

MONALEESA-2 Subgroup Analysis Highlights Survival Benefit With Ribociclib/Letrozole in HR+ Breast Cancer

<a href="https://news.google.com/rss/articles/CBMizAFBVV95cUxQMlBFSmxoM1V0SWpMV0x0eHRXU0RvTFFWV2c4NEJWTGt4QlkwWlNfekhzc3ZEQ0lQNXpiWmRiMy0tVERHdk1DMmczT2lGOGN2MFhlZjVSSTJyM0FSUkNQb2xOYnJQazhYSGprUUZEeFpROGlVTGY0YVA4MDc0Q2NFR04xUjBqTXVYcHdXcDNHdDJKRkVBemRXMlo5dXNIUXZrbnBfSzl5TGFoZ2tRU3Y2MFhiTnVUai15d2hYVXpRLXpHaUpyTXJEcFhYODE?oc=5" target="_blank">MONALEESA-2 Subgroup Analysis Highlights Survival Benefit With Ribociclib/Letrozole in HR+ Breast Cancer</a>  <font color="#6f6f6f">OncLive</font>

Read Full StoryMore like this
First-line Ribociclib Plus Letrozole Improved Survival for Postmenopausal HR+, HER2- Advanced Breast Cancer
CancerNetworkgeneral

First-line Ribociclib Plus Letrozole Improved Survival for Postmenopausal HR+, HER2- Advanced Breast Cancer

<a href="https://news.google.com/rss/articles/CBMi1wFBVV95cUxPdVNqSjNuZUVNTTlUNzF3dHpieFAzOEpMemdpclhUUmt3NVp6YTcyS084QXFqT0NRa3dwUVRDR2o5bTg4bVhRc0JITFFaRVhGRUFxOTlUVjl3VlRzVVROWDZkRVNiNTZKT1N5XzlRV0RhTld0ZTBkUVczdHBTNWRIbTFQcU90ajhGSU43WnlsVDQyRkJXaGQ0ekxzajZxRGNnUU5TWk5xUV9mT3lCMmhCdGlvejliQmc0dUlEQjlUSTEtalBrNkI1b1RHSXZMY09wSm1tVVlLUQ?oc=5" target="_blank">First-line Ribociclib Plus Letrozole Improved Survival for Postmenopausal HR+, HER2- Advanced Breast Cancer</a>  <font color="#6f6f6f">CancerNetwork</font>

Read Full StoryMore like this
2023 Dakar Rally: Stage 3 highlights
Enduro21 | Newsgeneral

2023 Dakar Rally: Stage 3 highlights

<a href="https://news.google.com/rss/articles/CBMickFVX3lxTE40VFVkZ3ZHQ1N2Ui05UWVXSHN4RE5XSDY4NWFZNV9KNnVvRURrVG9wN0g3S3FsSEM0ZFl3eGZGdGhfd1NhWnZOakVUV2J2UlNqLTBCUjJtWW9NRjB0d2J3UzNkekdGZnVOX2hxUFh2ZkgzUQ?oc=5" target="_blank">2023 Dakar Rally: Stage 3 highlights</a>  <font color="#6f6f6f">Enduro21 | News</font>

Read Full StoryMore like this
"Phase 3 Data Highlight Ha" — Live Google News Trends & Headlines